|
|
"Statistical Methods for Genetic Epidemiology"
|
5R01CA094069-10
|
$558,584
|
$189,919
|
Whittemore, Alice
|
STANFORD UNIVERSITY
|
|
|
15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor
|
5R01CA131445-04
|
$214,879
|
$214,879
|
NIE, DAOTAI
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
|
18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma
|
5R01CA129356-05
|
$234,999
|
$234,999
|
Schuster, David
|
EMORY UNIVERSITY
|
|
|
3D-Nanostrcutured Substrates for Detection of Circulating Tumor Cells
|
5R21CA151159-02
|
$194,941
|
$97,471
|
TSENG, HSIAN-RONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-04
|
$381,417
|
$95,354
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
|
A Genome-wide Association Study of Prostate Cancer in African Americans
|
3U01CA136792-03S1
|
$1,147,733
|
$1,147,733
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
A Genome-wide Association Study of Prostate Cancer in African Americans
|
5U01CA136792-03
|
$1,546,239
|
$1,546,239
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-02
|
$350,219
|
$87,555
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$94,010
|
$47,005
|
Kelly, Kathleen
|
CCR (NCI)
|
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-05
|
$284,400
|
$42,660
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
1U54CA155496-01
|
$1,814,496
|
$508,059
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
|
A Nanotechnology Enabled Diagnostic Platform for Early Stage Cancer Detection
|
2R44CA143232-02A1
|
$749,659
|
$749,659
|
Nelson, James
|
INANOVATE, INC.
|
|
|
A Network Analytic Approach to Modeling Variation in Prostate Cancer Care
|
1K07CA151910-01A1
|
$54,135
|
$54,135
|
Pollack, Craig
|
JOHNS HOPKINS UNIVERSITY
|
|
|
A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesis
|
1R01CA151623-01A1
|
$335,661
|
$335,661
|
SUN, ZIJIE
|
STANFORD UNIVERSITY
|
|
|
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
|
1R01CA138583-01A2
|
$280,125
|
$280,125
|
HAMBURGER, ANNE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
A Novel Synthetic Androgen Receptor Antagonist
|
5R01CA131137-04
|
$313,989
|
$313,989
|
DONG, ZHONGYUN
|
UNIVERSITY OF CINCINNATI
|
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
1R01CA150182-01A1
|
$296,474
|
$296,474
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-03
|
$706,671
|
$706,671
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Role of Novel Serpin Maspinin Prostate Tumor/Bone Interaction
|
5R01CA127735-04
|
$302,919
|
$302,919
|
SHENG, SHIJIE
|
WAYNE STATE UNIVERSITY
|
|
|
A Systems Biology Approach to the Development of Cancer Biomarkers
|
5U01CA111275-07
|
$695,128
|
$695,128
|
CHINNAIYAN, ARUL
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-13
|
$827,538
|
$165,508
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,178,242
|
$58,912
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-35
|
$7,696,742
|
$384,837
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-35S1
|
$50,000
|
$2,500
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Academic Training in Medical Oncology
|
3T32CA009297-28S1
|
$66,919
|
$6,692
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Academic Training in Medical Oncology
|
5T32CA009297-28
|
$316,308
|
$31,631
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Academic-industrial partnership for development of in vivo imaging systems and me
|
3R01CA133148-04S1
|
$56,254
|
$14,064
|
XU, CHRIS
|
CORNELL UNIVERSITY ITHACA
|
|
|
Academic-industrial partnership for development of in vivo imaging systems and me
|
5R01CA133148-04
|
$343,818
|
$85,955
|
XU, CHRIS
|
CORNELL UNIVERSITY ITHACA
|
|
|
Acceptance and Commitment Therapy for Erectile Dysfunction Following Radical Pros
|
5R21CA149536-02
|
$241,651
|
$241,651
|
Nelson, Christian
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Accurate Target Delineation and Motion Tracking to Improve IMRT Effectiveness
|
5K25CA123112-05
|
$145,830
|
$72,915
|
Wu, Xiaodong
|
UNIVERSITY OF IOWA
|
|
|
Ack1: A Critical Regulator of Hormone-Refractory Prostate Cancer
|
5R01CA135328-02
|
$328,873
|
$328,873
|
Mahajan, Nupam
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Ack1: Activation and Consequences in Prostate Cancer
|
4R01CA120304-03
|
$296,823
|
$296,823
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
1U10CA149950-01A1
|
$1,300,000
|
$130,000
|
SLOAN, JEFF
|
MAYO CLINIC
|
|
|
Adiposity and Outcomes of Clinically Localized Prostate Cancer
|
5R01CA129140-03
|
$592,478
|
$592,478
|
Freeman, Vincent
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
Advanced Development of An Integrated CTC Enrichment Technology
|
1R33CA157396-01
|
$225,000
|
$225,000
|
TSENG, HSIAN-RONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Advanced PET/CT Imaging for Improving Clincail Trials
|
5U01CA148131-02
|
$565,840
|
$282,920
|
KINAHAN, PAUL
|
UNIVERSITY OF WASHINGTON
|
|
|
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
|
5R01CA123194-05
|
$449,390
|
$449,390
|
Sillerud, Laurel
|
UNIVERSITY OF NEW MEXICO
|
|
|
Aging and Prostate Cancer Risk--the Role of T Cell Dysfunction
|
1R03CA156404-01A1
|
$76,875
|
$76,875
|
DE GRAFFENRIED, LINDA
|
UNIVERSITY OF TEXAS AUSTIN
|
|
|
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors
|
5R01CA127727-03
|
$313,989
|
$313,989
|
Garcia-Blanco, Mariano
|
DUKE UNIVERSITY
|
|
|
Amoeboid Membrane Dynamics in Prostate Cancer
|
5R01CA143777-02
|
$395,145
|
$395,145
|
FREEMAN, MICHAEL
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
An androgen receptor coactivator regulated in prostate
|
5R01CA112226-04
|
$341,161
|
$341,161
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
An androgen-regulated cytokine network controls prostate apoptosis
|
1R01CA151753-01A1
|
$317,475
|
$317,475
|
KROLEWSKI, JOHN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
An Interactive E-Health Program to Promote Health Behaviors among Cancer Survivor
|
1R03CA142042-01A2
|
$109,202
|
$37,129
|
KREBS, PAUL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Analyses of human T regulatory cells
|
ZIA BC 010973
|
$237,467
|
$71,240
|
Tsang, Kwong
|
CCR (NCI)
|
|
|
Analysis of Homing Receptors in Prostate Cancer
|
5R01CA118124-05
|
$274,238
|
$274,238
|
DIMITROFF, CHARLES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
|
ZIA BC 010425
|
$659,162
|
$263,664
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
|
Analysis of Lag-3 in Regulatory T Cell Function and Immune Supression
|
5R01CA127153-04
|
$330,091
|
$165,046
|
DRAKE, CHARLES
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Androgen and MicroRNAs in Prostate Cancer
|
1R01CA134697-01A2
|
$319,550
|
$319,550
|
DUTTA, ANINDYA
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
|
Androgen and Soluble Guanylyl Cyclase Signaling in Prostate Cancer
|
5R01CA127873-04
|
$182,282
|
$182,282
|
SHEMSHEDINI, LIRIM
|
UNIVERSITY OF TOLEDO
|
|
|
Androgen Receptor Function in Prostate Cancer
|
5R01CA086072-09
|
$310,970
|
$310,970
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Total relevant funding to Prostate for this search: $288,326,756
|
